MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...
MIRA Pharmaceuticals (MIRA) announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain.
Wockhardt Hospitals, Mira Road successfully performs first Swap Kidney Transplant: Our Bureau, Mumbai Thursday, March 13, 2025, 17:40 Hrs [IST] In a significant development that c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback